Projects per year
Search results
-
Stem Cell: Biomarkers Including Putative Stem Cells Markers in Human Breast Cancers
Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.
3/20/14 → …
Project: Clinical Trial
-
Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS
Chang, J. C., Niravath, P. A. & Singh, M.
3/20/14 → …
Project: Clinical Trial
-
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
Niravath, P. A., Chang, J. C. & Darcourt, J.
9/26/16 → 6/30/18
Project: Federal Funding Agencies
-
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Aromatase in Obese Subjects (CTMS# 15-2100)
Niravath, P. A., Chang, J. C. & Darcourt, J.
12/1/16 → 11/30/18
Project: Federal Funding Agencies
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
12/8/16 → 12/7/41
Project: Non Profit
-
NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Geyer, C. E., Chang, J. C., Darcourt, J. & Niravath, P. A.
3/12/19 → 2/28/25
Project: Non Profit
-
Converting HR+ Breast Cancer Into an Individualized Vaccine
Chang, J. C., Darcourt, J. & Niravath, P. A.
9/30/19 → 9/30/23
Project: Federal Funding Agencies
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.
4/9/20 → …
Project: Clinical Trial
-
MOCHA 1.2 Study
Stubbins, R. E., Niravath, P. A., Satkunasivam, R. & Wong, S. T.
1/25/21 → …
Project: Clinical Trial
-
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B., Chen, S., Niravath, P. A., Rosato, R. R. & Xu, S.
3/1/21 → 2/28/25
Project: Federal Funding Agencies
-
Texas Southern University Breast Cancer Prevention and Screening Center (TSU BCSPC)
10/1/21 → 8/30/24
Project: State
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2
Niravath, P. A., Chang, J. C., Heyne, K. & Singh, M.
Project: Clinical Trial
-
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative
Niravath, P. A., Butler, E. B., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B. & Teh, B. S.
Project: Clinical Trial
-
Acupuncture Trial
Niravath, P. A., Chang, J. C., Heyne, K., Mai, H. P., Singh, M. & Sun, K.
Project: Clinical Trial
-
Converting HR Breast Cancer Into an Individualized Vaccine
Chang, J. C., Mai, H. P., Niravath, P. A. & Sun, K.
Project: Clinical Trial
-
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast
Mai, H. P., Chang, J. C., Niravath, P. A. & Sun, K.
Project: Clinical Trial
-
-
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Templeton, S., Arentz, C., Chang, J. C., Darcourt, J., Dubrovsky, E., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Chang, J. C., Darcourt, J., Geyer, C. E. & Niravath, P. A.
Project: Clinical Trial
-
Katherine, B50, for Treatment of Adjuvant HER2 Positive Breast Cancer
Chang, J. C., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Sun, K., Chang, J. C., Mai, H. P., Niravath, P. A. & Templeton, S.
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
Niravath, P. A., Abdelrahim, M., Arentz, C., Chang, J. C., Heyne, K. & Singh, M.
Project: Clinical Trial
-
BO41843: Phase III_GDC-9545 RO7197597_Breast Cancer_Roche BO41843: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Niravath, P. A., Chang, J. C., Mai, H. P. & Sun, K.
Project: Clinical Trial